During the Trading Day
9.47 +0.03 / +0.32%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.47 0.00 / 0.00%
Volume: 21.3K
Health Technology

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company currently in developmental stage that seeks to acquire, develop and commercialize, on its own or with commercial partners, a diverse portfolio of cancer therapies. The company also has a portfolio of small molecule drug candidates, which are no longer a strategic focus of its development activities for which the company is seeking partners to pursue further development and commercialization. It is currently focused on two clinical stage product candidates: Ad-RTS-IL-12 + veledimex and DC-RTS-IL-12 + veledimex. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:



Individual stakeholders26.60%
Other institutional26.42%
Mutual fund holders11.94%

Top Executives

Laurence James Neil CooperChief Executive Officer & Managing Director
Kevin G. LafondTreasurer, Chief Accounting Officer & VP-Finance
J. Kris PiperVice President-Clinical Regulatory & Quality
Francois LebelChief Medical Officer, EVP-Research & Development
Caesar J. BelbelSecretary, Chief Legal Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account